Donna Winterrowd
Family · Munster, INNPI 1689620874
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Merck at 24.2% of the total. Reporting peaked in 2023 at $6,022 and has fallen 63.1% since, to $2,219 in 2025. Among family clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $61.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$4K
- Amgen$4K
- Eli Lilly$2K
- AstraZeneca$2K
- Novartis$2K
- Bayer$777
- plus $2K from 27 others
Across 17 payments — averaging $128.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim International GmbH$2K
- Novo Nordisk$50
What the payments were for
- Consulting fees$2,05012%
- Travel & lodging$6,98441%
- Food & beverage$7,94047%
- Other$790%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 61 | $4,128 |
| Amgen | 36 | $3,962 |
| Eli Lilly | 5 | $2,251 |
| AstraZeneca | 24 | $2,010 |
| Novartis | 25 | $1,542 |
| Bayer | 11 | $777 |
| Boehringer Ingelheim | 21 | $440 |
| Johnson & Johnson | 10 | $265 |
| Actelion Pharmaceuticals US, Inc. | 7 | $175 |
| Alnylam Pharmaceuticals Inc. | 7 | $172 |
| Vifor Pharma, Inc. | 6 | $129 |
| Regeneron Healthcare Solutions, Inc. | 6 | $123 |
| Esperion Therapeutics, Inc. | 9 | $113 |
| Abbott | 5 | $100 |
| Baxter Healthcare | 2 | $79 |
| Medtronic | 2 | $78 |
| Sanofi-aventis U.S. LLC | 5 | $76 |
| Chiesi USA, Inc. | 5 | $71 |
| Novo Nordisk | 3 | $65 |
| Scpharmaceuticals Inc. | 3 | $60 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $53 |
| Boston Scientific | 1 | $50 |
| Itamar Medical Inc | 1 | $49 |
| Atricure, Inc. | 3 | $48 |
| Lexicon Pharmaceuticals, Inc. | 3 | $46 |
| Cardiovascular Systems Inc. | 3 | $45 |
| W. L. Gore & Associates, Inc. | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Lantheus Medical Imaging, Inc. | 1 | $23 |
| Edwards Lifesciences | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,053 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $15,128 |
| Ezetimibe | 14 | $328 |
Paid to pharmacies, not to this prescriber.
Other family in Munster
- Monika VasicMunster$25K
- Sharon HennMunster$19K
- Jacquelyn AdleyMunster$16K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.